检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:檀立端[1] 武会志 陈治国[1] TAN Li-duan;WU Hui-zhi;CHEN Zhi-guo(Department of Emergency,Hebei Chengde Central Hosptial,Chengde Hebei,06700)
出 处:《世界最新医学信息文摘》2018年第24期32-34,共3页World Latest Medicine Information Electronic Version
摘 要:目的评价依达拉奉治疗急性百草枯中毒的治疗效果,为百草枯中毒的有效治疗提供循证医学依据。方法以"百草枯""依达拉奉为中文检索主题词,以"paraquat""edarabone"为英文检索主题词,检索检索Pub Med、EMbase、Cochrane、CBM、中国知网、万方和维普数据库,检索时限建库至2017年7月公开发表的论文,语种限定为中文和英文,收集依达拉奉联合常规治疗与常规治疗疗效对比的随机对照文献,筛选提取纳入研究的文献。采用5.3进行数据分析,比较依达拉奉联合常规治疗与常规治疗百草枯中毒的死亡率和肺纤维化率。结果共纳入7篇文献,依达拉奉联合常规治疗百草枯中毒的死亡率(95%置信区间0.28~0.64)和肺纤维化率(95%置信区间0.07~0.51),均低于常规对照组(P<0.0001;P=0.0008)。结论依达拉奉联合常规治疗百草枯中毒的死亡率和肺纤维化率,均低于常规治疗组。Objective To investigate the effectiveness of edarabone in the treatment of acute paraquat poisoning. We hope to it can provid evidence-based medicine for the therapy of paraquat poisoning. Methods The database such as Pub Med, EMbase, Cochrane, CBM, CNKI, Wan Fang and VIP Data were searched to collect randomized controlled trials published up to July, 2017. The subject words which included paraquat and edarabone were used for searching Chinese and English literature. Studies were screened, data were extracted. Rev Man5.3 were used for the analysis of the morbidity rate and pulmonary fibrosis rate after the edaravone combined with conventional treatment for acute paraquat poisoning. Results A total of 7 studies were included. The morbidity rate and pulmonary fibrosis rate of patients with edarabone combined with routine therapies for acute paraquat poisoning were significantly lower than those with routine therapies(OR=0.43, 95% CI=0.28 to 0.6, OR=0.20, 95% CI=0.07 to 0.51; P〈0.0001;P=0.0008). Conclusions Edaravone combined with routine treatment for acute paraquat poisoning can reduce the mortality and pulmonary fibrosis rate.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.7